Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Nature ; 527(7578): S151-4, 2015 Nov 19.
Article in English | MEDLINE | ID: mdl-26580320

ABSTRACT

This is an exciting time for scientific discovery that aims to reduce the frequency and impact of neurological, mental health and substance-use disorders. As it became increasingly clear that low- and middle-income countries have a disproportionate share of these disorders, and that many of the problems are best addressed by indigenous researchers who can seek context-sensitive solutions, the US National Institutes of Health and other research funders began to invest more in low- and middle-income country-focused research and research capacity-building to confront this significant public health challenge. In an effort to identify existing information, knowledge gaps, and emerging research and research capacity-building opportunities that are particularly relevant to low- and middle-income countries, in February 2014 the Center for Global Health Studies at the National Institutes of Health Fogarty International Center held a workshop to explore these issues with scientific experts from low- and middle-income countries and the United States. This evolved into the preparation of the Reviews in this supplement, which is designed to highlight opportunities and challenges associated with topical areas in brain-disorders research over the coming decade. This Introduction highlights some of the over-arching and intersecting priorities for addressing causes, prevention, treatment and rehabilitation as well as best practices to promote overall nervous system health. We review some brain disorders in low- and middle-income countries, while the Reviews describe relevant issues and the epidemiology of particular conditions in greater depth.


Subject(s)
Aging , International Cooperation , Nervous System Diseases , Adult , Biomedical Research/economics , Biomedical Research/organization & administration , Brain Diseases/economics , Brain Diseases/epidemiology , Child , Cost of Illness , Developing Countries/economics , Developing Countries/statistics & numerical data , Humans , National Institutes of Health (U.S.)/organization & administration , Nervous System Diseases/economics , Nervous System Diseases/epidemiology , Research Support as Topic , Substance-Related Disorders/economics , Substance-Related Disorders/epidemiology , United States
2.
J Acquir Immune Defic Syndr ; 67 Suppl 1: S2-7, 2014 Sep 01.
Article in English | MEDLINE | ID: mdl-25117958

ABSTRACT

In this special 2014 issue of JAIDS, international investigator teams review a host of noncommunicable diseases (NCDs) that are often reported among people living and aging with HIV in sub-Saharan Africa. With the longer lifespans that antiretroviral therapy programs have made possible, NCDs are occurring due to a mix of chronic immune activation, medication side effects, coinfections, and the aging process itself. Cancer; cardiovascular and pulmonary diseases; metabolic, body, and bone disorders; gastrointestinal, hepatic, and nutritional aspects; mental, neurological, and substance use disorders; and renal and genitourinary diseases are discussed. Cost-effectiveness, key research methods, and issues of special importance in Asia, Latin America, and the Caribbean are also addressed. In this introduction, we present some of the challenges and opportunities for addressing HIV and NCD comorbidities in low- and middle-income countries, and preview the research agenda that emerges from the articles that follow.


Subject(s)
Comorbidity/trends , HIV Infections/epidemiology , Africa South of the Sahara/epidemiology , Anti-Retroviral Agents/therapeutic use , Antiretroviral Therapy, Highly Active , Asia/epidemiology , Caribbean Region/epidemiology , Developing Countries , HIV Infections/drug therapy , Humans , Latin America/epidemiology
3.
Acad Med ; 84(4): 525-34, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19318794

ABSTRACT

The scientific diaspora is a unique resource for U.S. universities. By drawing on the expertise, experience, and catalytic potential of diaspora scientists, universities can capitalize more fully on their diverse intellectual resources to make lasting contributions to global health. This article examines the unique contributions of the diaspora in international research collaborations, advantages of harnessing the diaspora and benefits to U.S. universities of fostering these collaborations, challenges faced by scientists who want to work with their home countries, examples of scientists engaging with their home countries, and specific strategies U.S. universities and donors can implement to catalyze these collaborations. The contributions of the diaspora to the United States are immense: International students enrolled in academic year 2007-2008 contributed an estimated $15 billion to the U.S. economy. As scientific research becomes increasingly global, the percentage of scientific publications with authors from foreign countries has grown from 8% in 1988 to 20% in 2005. Diaspora scientists can help build trusting relationships with scientists abroad, and international collaborations may improve the health of underserved populations at home. Although opportunities for diaspora networks are increasing, most home countries often lack enabling policies, infrastructure, and resources to effectively utilize their diaspora communities abroad. This article examines how some governments have successfully mobilized their scientific diaspora to become increasingly engaged in their national research agendas. Recommendations include specific strategies, including those that encourage U.S. universities to promote mini-sabbaticals and provide seed funding and flexible time frames.


Subject(s)
International Cooperation , Research Personnel , Emigrants and Immigrants , Foreign Medical Graduates , Humans , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...